Rationale and design of the ETN-STEP (Early administration of Tirofiban in mid to high risk patients with non-ST elevation acute coronary syndrome referred for percutaneous coronary intervention) project: A multi-center, randomized, controlled clinic trial in Chinese patients

As a member of Glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitors, Tirofiban had been shown to improve myocardial reperfusion and clinical outcomes in patients undergoing percutaneous coronary intervention (PCI), but the optimal timing of administration of Tirofiban remains unclear. In order to compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jian-Ping, Liu, Qun, Huo, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545255/
https://www.ncbi.nlm.nih.gov/pubmed/23341842
http://dx.doi.org/10.3724/SP.J.1263.2012.02272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545255/
https://www.ncbi.nlm.nih.gov/pubmed/23341842
http://dx.doi.org/10.3724/SP.J.1263.2012.02272

Ejemplares similares